ELMED Life Sciences

ELMED LIFE SCIENCES PRIVATE LIMITED

2018

Founded in 2018, ELMED Life Sciences operates in Health Tech offering science-driven microbiome solutions that advance the Global One Health approach across human health, animal health, and agricultur...

Funding stage:

Series A

Last funding:

25/03/2026

Total funding:

$2.70 Mn+

Revenue:

₹17.0 Cr+ (FY25)

Prev. FY

Investors

Employee count:

Last 90d

Web traffic:

Last 30d

ELMED Life Sciences: Financial Breakdown

Decoding financial health metrics of ELMED Life Sciences

Total Revenue
₹17.0 Cr
48%
Prev. FY
Total Expenses
₹14.8 Cr
39%
Prev. FY
Profit After Tax
₹2.1 Cr
133%
Prev. FY
Total Assets
₹17.5 Cr
-5%
Prev. FY
Net Profit Margin
12.2%
57%
Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of ELMED Life Sciences

Yes. In FY25, ELMED Life Sciences reported a profit after tax of ₹2.1 Cr, making it profitable.

ELMED Life Sciences's revenue grew 48.3% year-on-year, from ₹11.4 Cr in FY24 to ₹17.0 Cr in FY25.

ELMED Life Sciences's estimated EBITDA for FY25 was ₹4.0 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.

In FY25, ELMED Life Sciences posted revenue of ₹17.0 Cr (up 48.3% YoY) and a profit after tax of ₹2.1 Cr. Explore the full financials of ELMED Life Sciences here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

ELMED Life Sciences - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

ELMED Life Sciences: Financial Breakdown

FAQs on Financials of ELMED Life Sciences

Is ELMED Life Sciences profitable?

What is ELMED Life Sciences's growth rate?

What is ELMED Life Sciences's EBITDA?

How is ELMED Life Sciences's business performing?

Disclaimer